Science & Environnement
optional screen reader
Denmark terminates use of AstraZeneca vaccine in European first
-
U.S. Seeks to Pause J&J Shot After Rare Clotting Cases
CDC and FDA urge the pause on the Covid vaccine over six reported US cases of a 'rare and severe' blood clot. Nearly 7 million doses have been given.
-
Pfizer, BioNTech say study of COVID-19 patients six months after second vaccine dose proved it is safe and effective
"It is an important step to further confirm the strong efficacy and good safety data we have seen so far," BioNTech CEO Ugur Sahin said.
-
Opinion: Vaccine passports are already turning into a culture war
The next thing to know about vaccine passports is they’re about to start a war anyway.
Latest Science & Environnement
Covid-19 Vaccination Cards Are the Only Proof of Shots, Soon an Essential
The U.S. lacks a central database for immunizations due to privacy concerns, leaving non-standardized impermanent cards as the sole record of shots
- By
Introducing ‘Vaxzevria’: AstraZeneca renames Covid vaccine as firm fights off controversy over drug
AstraZeneca has renamed its Covid-19 vaccine, a move that coincides with the company’s struggle to reassure the public that its drug is safe, following numerous reports of potential adverse effects.
- By
Pfizer begins early stage clinical trial testing oral antiviral drug for Covid
Pfizer said it has begun an early stage clinical trial testing its experimental oral antiviral drug for Covid-19.
- By
AstraZeneca says US data shows COVID-19 vaccine prevents 79% of symptomatic disease
It would be the fourth vaccine authorized for use in the U.S., alongside ones from Pfizer-BioNTech, Moderna, and Johnson & Johnson.
- By
‘No evidence’: Vaccine claim rubbished
The chief medical officer says there is no need to suspend the AstraZeneca vaccine rollout, after two government-aligned MPs called for a pause.
- By
Russia accused of spreading vaccine disinformation to protect Sputnik V
Russian officials have dismissed accusations that they spread disinformation about rival vaccines as “nonsense”.
- By
Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US
The J&J vaccine was found in its large trial to be 72% effective in the USA but less effective in South Africa and Latin America, where variants circulated.
- By
Moderna study suggests half doses offer strong immune response, but experts caution against changing approach
'Significant' immune response from both full and half doses, company's team says
- By
COVID-19 in the UK: South African strain spreads
Concerns are mounting in the UK after the South African mutant strain was detected in eight areas, with no cases linked to international travel.
- By
US north-east hit by snowstorm with blizzard-like conditions predicted
New York, New Jersey and Connecticut may see 18in of snow, with storm reaching Massachusetts and northern New England Monday
- By
Coronavirus: Moderna vaccine ‘effective’ against South African strain
A vaccine manufacturer says it believes it can combat a highly-contagious new COVID-19 strain as Jacinda Ardern delivers a virus-related warning.
- By
France’s Pasteur Institute says it is abandoning its principal Covid-19 vaccine project
France's Pasteur Institute said on Monday it was ending development of a Covid-19 vaccine with US pharmaceutical company Merck after clinical trial results proved disappointing.
- By
Covid-19: Pfizer-BioNTech vaccine works against UK, South African variants, study says
German company BioNTech said Friday a preliminary study shows that its vaccine works against a key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than normal coronavirus strains.
- By
The Coronavirus Is Mutating. What Does That Mean for Us?
Officials in Britain and South Africa claim new variants are more easily transmitted. There’s a lot more to the story, scientists say.
- By
Britain becomes the first country to license a fully tested covid-19 vaccine
Inoculations with the Pfizer-BioNTech jab could start in less than a week
- By
Moderna To Ask U.S., European Regulators To Allow Use Of COVID-19 Vaccine
Moderna said it got the final needed results over the weekend that suggest its vaccine is more than 94% effective.
- By
